Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
Azenta (Nasdaq: AZTA) is set to announce its fiscal third quarter 2024 earnings on Tuesday, August 6, 2024, after the market closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Azenta (Nasdaq: AZTA) is set to announce its fiscal third quarter 2024 earnings on Tuesday, August 6, 2024, after the market closes. The earnings pertain to the quarter ending on June 30, 2024. The company will also host a conference call and live webcast to discuss the financial results at 4:30 p.m. Eastern Time on the same day. Interested parties, including analysts, investors, and media, can access the live webcast through the Azenta website. Additionally, a replay of the webcast will be available starting at 8:30 a.m. ET on August 7, 2024.
Details
News Market Reaction – AZTA
The recorded move for AZTA in the trading session of this news was +3.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, August 6, 2024, at 4:30 p.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on August 7, 2024.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-announces-fiscal-2024-third-quarter-earnings-conference-call-and-webcast-302205805.html
SOURCE Azenta
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.